BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32297416)

  • 1. Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study.
    Foucar K; Hsi ED; Wang SA; Rogers HJ; Hasserjian RP; Bagg A; George TI; Bassett RL; Peterson LC; Morice WG; Arber DA; Orazi A; Bueso-Ramos CE;
    Int J Lab Hematol; 2020 Aug; 42(4):418-422. PubMed ID: 32297416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology.
    Osman M; Akkus Z; Jevremovic D; Nguyen PL; Roh D; Al-Kali A; Patnaik MM; Nanaa A; Rizk S; Salama ME
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34073699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.
    Orazi A; Chiu R; O'Malley DP; Czader M; Allen SL; An C; Vance GH
    Mod Pathol; 2006 Dec; 19(12):1536-45. PubMed ID: 17041567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia.
    Bueso-Ramos CE; Rocha FC; Shishodia S; Medeiros LJ; Kantarjian HM; Vadhan-Raj S; Estrov Z; Smith TL; Nguyen MH; Aggarwal BB
    Hum Pathol; 2004 Feb; 35(2):246-53. PubMed ID: 14991544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cells.
    Kern W; Bacher U; Haferlach C; Schnittger S; Haferlach T
    Leuk Lymphoma; 2011 Jan; 52(1):92-100. PubMed ID: 21219126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRF8 is a Reliable Monoblast Marker for Acute Monocytic Leukemias.
    Katz SG; Edappallath S; Xu ML
    Am J Surg Pathol; 2021 Oct; 45(10):1391-1398. PubMed ID: 34172624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry:  A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.
    Harrington AM; Schelling LA; Ordobazari A; Olteanu H; Hosking PR; Kroft SH
    Am J Clin Pathol; 2016 Aug; 146(2):170-81. PubMed ID: 27413139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories.
    Loghavi S; Sui D; Wei P; Garcia-Manero G; Pierce S; Routbort MJ; Jabbour EJ; Pemmaraju N; Kanagal-Shamanna R; Gur HD; Hu S; Zuo Z; Medeiros LJ; Kantarjian HM; Khoury JD
    Blood Adv; 2018 Aug; 2(15):1807-1816. PubMed ID: 30054307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD 34 immunotyping of blasts in myelodysplasia.
    Oertel J; Oertel B; Beyer J; Huhn D
    Ann Hematol; 1994 Feb; 68(2):77-80. PubMed ID: 7511934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.
    Amin HM; Yang Y; Shen Y; Estey EH; Giles FJ; Pierce SA; Kantarjian HM; O'Brien SM; Jilani I; Albitar M
    Leukemia; 2005 Sep; 19(9):1567-72. PubMed ID: 16049515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological evaluation of monocytes and their precursors.
    Goasguen JE; Bennett JM; Bain BJ; Vallespi T; Brunning R; Mufti GJ;
    Haematologica; 2009 Jul; 94(7):994-7. PubMed ID: 19535346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CML with Megakaryocytic Blast Crisis: Report of 3 Cases.
    Khemka R; Gupta M; Jena NK
    Pathol Oncol Res; 2019 Jul; 25(3):1253-1258. PubMed ID: 30357754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
    Feng R; Bhatt VR; Fu K; Pirruccello S; Yuan J
    Cytometry B Clin Cytom; 2018 Nov; 94(6):901-909. PubMed ID: 30334354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
    Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
    Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden blast phase in pediatric chronic myeloid leukemia-chronic phase with abnormal lymphoid blasts detected by flow cytometry at diagnosis: Can it be considered a warning sign?
    Vijayasekharan K; Chatterjee G; Ramanathan S; Narula G; Tembhare P; Subramanian PG; Patkar N; Gujral S; Shetty D; Banavali S
    Cytometry B Clin Cytom; 2021 May; 100(3):345-351. PubMed ID: 33030302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Undifferentiated blastic cell crisis of chronic myelogenous leukemia with myeloblastic tumor in the skin].
    Kawakami K; Kiyosaki M; Amaya H; Nakamaki T; Hino K; Tomoyasu S
    Rinsho Ketsueki; 2000 Apr; 41(4):334-40. PubMed ID: 10846465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.